Detection of circulating tumour <scp>DNA</scp> in patients with aggressive B‐cell non‐Hodgkin lymphoma
Philippe Armand(Harvard University), Arnold S. Freedman(Otsuka (Japan)), Craig Cummings, Jennifer R. Brown(Dana-Farber Cancer Institute), Maria Alma Rodriguez(The University of Texas MD Anderson Cancer Center), Mark Klinger, Li Weng, Caron A. Jacobson(Dana-Farber Cancer Institute), Yasuhiro Oki(The University of Texas MD Anderson Cancer Center), Nathan Fowler(The University of Texas MD Anderson Cancer Center), Scott J. Rodig(Brigham and Women's Hospital), Matthew S. Davids(Harvard University), Sattva S. Neelapu(Unknown), Anas Younes(Memorial Sloan Kettering Cancer Center), Eric D. Jacobsen(Dana-Farber Cancer Institute), Ann S. LaCasce(Otsuka (Japan)), David C. Fisher(Otsuka (Japan)), Sangeetha Bhattar(Dana-Farber Cancer Institute), Malek Faham, Donna Neuberg(Otsuka (Japan))
Cited by 72
Related Papers
Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for <i>Fungi</i>
|Proceedings of the National Academy of Sciences|2012|5.1k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k